Randomized trial with over 30.000 patients showed AstraZeneca vaccine was safe and resulted in 74% efficacy against symptomatic SARS-CoV-2 infection.
30 Sep, 2021 | 10:32h | UTC
Commentaries on Twitter
https://twitter.com/NEJM/status/1443331005050355715
https://twitter.com/EricTopol/status/1443336261897392133